Drugs Made In America Acq...

NASDAQ: DMAA · Real-Time Price · USD
10.27
-0.01 (-0.10%)
At close: Aug 15, 2025, 3:56 PM
10.27
0.00%
After-hours: Aug 15, 2025, 04:00 PM EDT

Drugs Made In America Acquisition Ordinary Shares Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-476.19K -145.26K -144.98K -54.93
Interest Income
1.59M n/a n/a n/a
Pretax Income
1.11M -145.26K -144.98K -54.93
Net Income
1.11M -145.26K -144.98K -54.93
Selling & General & Admin
476.19K 145.26K 144.98K 54.93
Research & Development
n/a n/a n/a n/a
Other Expenses
n/a n/a n/a n/a
Operating Expenses
476.19K 145.26K 144.98K 54.93
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
186.33K -144.59K -144.87K 54.93
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
9.61K 8.57K 8.57K 8.57K
Shares Outstanding (Diluted)
25.51K 8.57K 8.57K 8.57K
EPS (Basic)
130.47 -0.04 -0.01 -0.01
EPS (Diluted)
49.14 -0.04 -0.01 -0.01
EBITDA
-475.85K -144.93K -144.93K n/a
EBIT
-476.19K -145.26K -144.98K -54.93
Depreciation & Amortization
334.81 334.81 54.93 54.93